Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Heparin for Second Degree Burns
NCT02497326Unknown
- Sponsor
- King Edward Medical University
- Start
- Apr 2015
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of heparin in burn injury, sponsored by King Edward Medical University. Primary endpoint: Total consumption of Analgesic Medication at 5 days. Status: unknown.
02
Drugs
heparin
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT02497326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497326.